Bank of Montreal’s Tiziana Life Sciences TLSA Stock Holding History

Bank of Montreal’s Portfolio TLSA Stock Details TLSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-25,000	Closed	-$30K	–	4452
2022 Q1	$30K	Hold	25,000	–	–	﹤0.01%	3871
2021 Q4	$26K	Buy	+25,000	New	+$33.1K	﹤0.01%	3318
2020 Q2	–	Sell	-50	Closed	–	–	4831
2020 Q1	$0	Buy	+50	New	+$48	﹤0.01%	4689

Other funds holding TLSA

HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AFP

Ausdal Financial Partners Davenport, Iowa $2.25B AUM 20.11% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

WAM

Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return

Zhang Financial Portage, Michigan $3.42B AUM 23.04% 1-Year Est. Return

Bank of Montreal's TLSA Position: Q2 2022 in Review

Bank of Montreal sold out of Tiziana Life Sciences (TLSA) in Q2 2022, closing a stake of 25,000 shares — an estimated $30K sold.

Bank of Montreal first reported a position in TLSA in Q1 2020 and held it in 3 quarters. The position peaked at $30K in Q1 2022. 24 funds tracked by Wall St. Rank hold TLSA as of Q2 2022.

Bank of Montreal reported no remaining Tiziana Life Sciences position as of Q2 2022 after selling out during the quarter.
Bank of Montreal sold 25,000 Tiziana Life Sciences shares in Q2 2022, an estimated $30K.
Bank of Montreal first reported a position in Tiziana Life Sciences in Q1 2020 and held it in 3 quarters.
Bank of Montreal's Tiziana Life Sciences position peaked at $30K in Q1 2022.
24 funds tracked by Wall St. Rank held Tiziana Life Sciences as of Q2 2022.

Based on Bank of Montreal's 13F filing for Q2 2022, filed 11 Aug 2022.